Ketamine/naltrexoneLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1948卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35808-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：251 / 251

相关论文

共 50 条

[1] AntihypertensivesLack of efficacy and off label use : case report
Reactions Weekly, 2021, 1871 (1) : 47 - 47
[2] AntineoplasticsLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1975 (1) : 42 - 42
[3] AntineoplasticsLack of efficacy and off label use: case report
Reactions Weekly, 2020, 1823 (1) : 56 - 56
[4] AntineoplasticsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1853 (1) : 51 - 51
[5] PaclitaxelLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1879 (1) : 306 - 306
[6] SulindacLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1964 (1) : 384 - 384
[7] DexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1933 (1) : 177 - 177
[8] DexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2054 (1) : 144 - 144
[9] AntidepressantsLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1919 (1) : 53 - 53
[10] AnidulafunginLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2044 (1) : 34 - 34

← 1 2 3 4 5 →